Biotech StocksInsights Analyst Sees Over 160% Upside for IntelliPharmaCeutics Intl Inc (USA) Stock It can be tricky putting a price tag on a biotech company, especially one that offers no profits but promises of big success … Jason Cohen, January 19, 2018
Biotech StocksStock News A Glimpse Into the Biotech Sector: Intercept Pharmaceuticals Inc (ICPT), IntelliPharmaCeutics Intl Inc (USA) (IPCI) Intercept Pharmaceuticals Inc (NASDAQ:ICPT) management hosted a conference call this morning to address Ocaliva safety concerns. As a reminder, company issued a Healthcare … Smarter Team, September 25, 2017
Biotech StocksInsights Maxim Slashes Price Target For IntelliPharmaCeutics Intl Inc (USA) (IPCI); Here’s Why In a research report issued Thursday, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI), while … Jason Cohen, July 27, 2017
Biotech StocksStock News IntelliPharmaCeutics Intl Inc (USA) (IPCI) Sinks on Negative FDA Ad Com Vote IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) shares are sinking nearly 40% pre-market on robust volume in response to a negative advisory committee vote for … Corey Williams, July 27, 2017
Biotech StocksInsights Aegis Drops Coverage of IntelliPharmaCeutics Intl Inc (USA) (IPCI) In a note issued short while ago, Aegis analyst Difei Yang dropped coverage of IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI). Her previous Hold rating and price … Jason Cohen, April 27, 2017
Biotech StocksStock News IntelliPharmaCeutics Intl Inc (USA) Rockets on Generic Glucophage XR Approval From FDA IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) received final approval from the FDA for the Company’s abbreviated new drug application for metformin hydrochloride extended release … Corey Williams, February 24, 2017
Biotech StocksLong IdeasMost Popular IntelliPharmaCeutics Intl Inc (USA) (IPCI): NDA Acceptance For Rexista May Not Be A Stock-Moving Event, Says Aegis In a research note released Friday, Aegis analyst Difei Yang reiterated coverage on shares of IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) with a Buy rating and … Peter Murray, Editor, February 3, 2017
Biotech StocksMost PopularStock News Company Update (NASDAQ:IPCI): IntelliPharmaCeutics Intl Inc (USA) Announces FDA Acceptance Of Filing Of New Drug Application For Pain Treatment Rexista IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) announced that the FDA has accepted for filing the Company’s previously-announced New Drug Application (NDA) seeking authorization to … Corey Williams, February 2, 2017
Biotech StocksStock News Company Update (NASDAQ:IPCI): IntelliPharmaCeutics Intl Inc (USA) Announces Par Pharmaceutical’s Launch of Additional Strengths of Generic Focalin XR Capsules IntelliPharmaCeutics Intl Inc (USA) (NASDAQ: IPCI) announced that its United States (“U.S. Corey Williams, January 6, 2017
Biotech StocksStock News Stock Update (NASDAQ:IPCI): IntelliPharmaCeutics Intl Inc (USA) Announces Issuance of U.S. and Canadian Patents Covering Aspects of its PODRAS Overdose Technology IntelliPharmaCeutics Intl Inc (USA) (NASDAQ: IPCI) announced that U.S. Corey Williams, December 21, 2016
